Sheldon Kaufman
- Oncology top 10%
- Cancer Treatment and Pharmacology 3
- Vascular Tumors and Angiosarcomas 2
- Hepatology top 10%
-
- Medical Imaging and Pathology Studies 4
-
- Bladder and Urothelial Cancer Treatments 4
- Urinary and Genital Oncology Studies 4
-
- Urological Disorders and Treatments 3
-
- Diphtheria, Corynebacterium, and Tetanus 2
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Robert W. CareyWilliam C. WoodGeorge R. ProutWilliam U. ShipleyNoah C. ChoiAndrew L. WarshawGeorge E. BattitJoel E. Tepper
- Journals
- New England Journal of Medicine (9 papers)Cancer (8 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- United StatesItalyIsrael
In The Last Decade
Sheldon Kaufman
31 papers receiving 609 citations
Peers
Comparison fields: 5 of 67
- Oncology 356
- Hepatology 65
- Pulmonary and Respiratory Medicine 245
- Surgery 247
- Cancer Research 71
Countries citing papers authored by Sheldon Kaufman
This map shows the geographic impact of Sheldon Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Kaufman more than expected).
Fields of papers citing papers by Sheldon Kaufman
This network shows the impact of papers produced by Sheldon Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Kaufman. The network helps show where Sheldon Kaufman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheldon Kaufman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 13 | |
| 2 | 1996 | 1 | |
| 3 | Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. | 1995 | 2 |
| 4 | 1993 | 12 | |
| 5 | 1989 | 4 | |
| 6 | 1988 | 26 | |
| 7 | 1987 | 49 | |
| 8 | 1987 | 47 | |
| 9 | 1984 | 128 | |
| 10 | 1983 | 54 | |
| 11 | 1982 | 3 | |
| 12 | 1981 | 39 | |
| 13 | 1979 | 16 | |
| 14 | 1977 | 10 | |
| 15 | 1976 | 52 | |
| 16 | 1975 | 8 | |
| 17 | 1975 | 1 | |
| 18 | 1974 | 5 | |
| 19 | 1971 | 6 | |
| 20 | [Heparin treatment in three cases of defibrination]. | 1970 | 1 |
About Sheldon Kaufman
Sheldon Kaufman is a scholar working on Oncology, Urology, Endocrinology, Surgery and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 666 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Urinary and Genital Oncology Studies (4 papers), Medical Imaging and Pathology Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Urological Disorders and Treatments (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Diphtheria, Corynebacterium, and Tetanus (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (356 citations), Hepatology (65 citations), Pulmonary and Respiratory Medicine (245 citations), Surgery (247 citations) and Cancer Research (71 citations). Sheldon Kaufman has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Robert W. Carey, William C. Wood, George R. Prout, William U. Shipley, Noah C. Choi, Andrew L. Warshaw, George E. Battit, Joel E. Tepper, Alan J. Greenfield and Alfred M. Cohen. Their work appears in journals such as New England Journal of Medicine, Cancer, International Journal of Radiation Oncology*Biology*Physics, The Journal of Urology and Psychosomatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.